Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Device therapy in heart failure patients with chronic kidney disease.
Badheka A, Rathod A, Tuliani T, Afonso L, Jacob S.
J Am Coll Cardiol. 2012 Jan 31;59(5):542-3. No abstract available.
Related citations
Low levels of circulating troponin as an intermediate phenotype in the pathway to heart failure.
de Lemos JA, Grundy SM.
J Am Coll Cardiol. 2012 Jan 31;59(5):490-2. No abstract available.
Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction.
Tartière-Kesri L, Tartière JM, Logeart D, Beauvais F, Cohen Solal A.
J Am Coll Cardiol. 2012 Jan 31;59(5):455-61.
Vasodilators across the heart failure spectrum not all patients, and not all vasodilators, are created equal.
Solomon SD.
J Am Coll Cardiol. 2012 Jan 31;59(5):452-4. No abstract available.
Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA.
J Am Coll Cardiol. 2012 Jan 31;59(5):442-51.
Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry.
Waldum B, Westheim AS, Sandvik L, Flønæs B, Grundtvig M, Gullestad L, Hole T, Os I.
J Am Coll Cardiol. 2012 Jan 24;59(4):371-8.
Exercise training as treatment of depression in heart failure.
Milani RV, Lavie CJ, Mehra MR, Ventura HO.
J Am Coll Cardiol. 2012 Jan 17;59(3):291. No abstract available.
Pulmonary pressures and death in heart failure: a community study.
Bursi F, McNallan SM, Redfield MM, Nkomo VT, Lam CS, Weston SA, Jiang R, Roger VL.
J Am Coll Cardiol. 2012 Jan 17;59(3):222-31.
Home monitoring for heart failure management.
Bui AL, Fonarow GC.
J Am Coll Cardiol. 2012 Jan 10;59(2):97-104. Review.
Determinants of exercise intolerance in heart failure with preserved ejection fraction.
Halbe JK, Sweitzer NK.
J Am Coll Cardiol. 2011 Dec 6;58(24):2547-8; author reply 2548-9. No abstract available.
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure.
Ramani R, Vela D, Segura A, McNamara D, Lemster B, Samarendra V, Kormos R, Toyoda Y, Bermudez C, Frazier OH, Moravec CS, Gorcsan J 3rd, Taegtmeyer H, McTiernan CF.
J Am Coll Cardiol. 2011 Nov 22;58(22):2270-8.
Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
Thijssen J, Borleffs CJ, Delgado V, van Rees JB, Mooyaart EA, van Bommel RJ, van Erven L, Boersma E, Bax JJ, Schalij MJ.
J Am Coll Cardiol. 2011 Nov 22;58(22):2282-9.
Myocardial expression levels of micro-ribonucleic acids in patients with left ventricular assist devices signature of myocardial recovery, signature of reverse remodeling, or signature with no name?
Mann DL, Burkhoff D.
J Am Coll Cardiol. 2011 Nov 22;58(22):2279-81. No abstract available.
The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study.
Elder DH, Wei L, Szwejkowski BR, Libianto R, Nadir A, Pauriah M, Rekhraj S, Lim TK, George J, Doney A, Pringle SD, Choy AM, Struthers AD, Lang CC.
J Am Coll Cardiol. 2011 Nov 8;58(20):2084-91.
Persistent left superior vena cava with retrograde drainage from the left atrium into the left brachiocephalic vein.
Chen YA, Joshi SB, Crean AM, Yan AT, Latter DA, Jimenez-Juan L, Kirpalani A.
J Am Coll Cardiol. 2011 Nov 8;58(20):2141. No abstract available.
The early intertwining of the heart and the kidney through an impaired natriuretic response to acute volume expansion.
Mullens W, Tang WH.
J Am Coll Cardiol. 2011 Nov 8;58(20):2104-5. No abstract available.
Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction.
McKie PM, Schirger JA, Costello-Boerrigter LC, Benike SL, Harstad LK, Bailey KR, Hodge DO, Redfield MM, Simari RD, Burnett JC Jr, Chen HH.
J Am Coll Cardiol. 2011 Nov 8;58(20):2095-103.
Relationship between sodium intake and sleep apnea in patients with heart failure.
Kasai T, Arcand J, Allard JP, Mak S, Azevedo ER, Newton GE, Bradley TD.
J Am Coll Cardiol. 2011 Nov 1;58(19):1970-4.
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Rossignol P, Ménard J, Fay R, Gustafsson F, Pitt B, Zannad F.
J Am Coll Cardiol. 2011 Nov 1;58(19):1958-66.
The month after a novel tale on eplerenone, but with a different ending.
Emdin M, Pastormerlo LE, Passino C.
J Am Coll Cardiol. 2011 Nov 1;58(19):1967-9. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on